Market Tracker

11/24 12:36pm ET
74.17
Real-Time Quote
 +1.90 / +2.63%
Today’s Change
40.30
Today|||52-Week Range
74.82
+46.49%
Year-to-Date

Today’s Trading

Previous close72.27
Today’s open72.50
Day’s range72.30 - 74.82
Volume773,615
Average volume (3 months)1,139,722
Market cap$12.2B
Dividend yield--
Data as of 12:21pm ET, 11/24/2014

Growth & Valuation

Earnings growth (last year)-64.71%
Earnings growth (this year)+79.57%
Earnings growth (next 5 years)+79.00%
Revenue growth (last year)+19.49%
P/E ratioNM
Price/Sales21.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+1.10+1.28%
ENDPEndo International P...+3.17+4.52%
PCYCPharmacyclics Inc+1.06+0.76%
JAZZJazz Pharmaceuticals...+0.66+0.39%
Data as of 12:36pm ET, 11/24/2014

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$354.9M
Annual profit (last year)-$83.1M
Net profit margin-23.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts